Role of Natural Compounds as Anti-Cancer Agents
- Авторлар: Tossetta G.1
-
Мекемелер:
- Department of Experimental and Clinical Medicine,, Università Politecnica delle Marche
- Шығарылым: Том 25, № 5 (2025)
- Беттер: 293-294
- Бөлім: Oncology
- URL: https://kld-journal.fedlab.ru/1871-5206/article/view/694491
- DOI: https://doi.org/10.2174/187152062505241230162647
- ID: 694491
Дәйексөз келтіру
Толық мәтін
Авторлар туралы
Giovanni Tossetta
Department of Experimental and Clinical Medicine,, Università Politecnica delle Marche
Email: info@benthamscience.net
Әдебиет тізімі
- Campagna, R.; Pozzi, V.; Giorgini, S.; Morichetti, D.; Goteri, G.; Sartini, D.; Serritelli, E.N.; Emanuelli, M. Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance. Hum. Cell, 2023, 36(3), 1108-1119. doi: 10.1007/s13577-023-00892-9 PMID: 36897549
- Campagna, R.; Belloni, A.; Pozzi, V.; Salvucci, A.; Notarstefano, V.; Togni, L.; Mascitti, M.; Sartini, D.; Giorgini, E.; Salvolini, E.; Santarelli, A.; Lo Muzio, L.; Emanuelli, M. Role played by paraoxonase-2 enzyme in cell viability, proliferation and sensitivity to chemotherapy of oral squamous cell carcinoma cell lines. Int. J. Mol. Sci., 2022, 24(1), 338. doi: 10.3390/ijms24010338 PMID: 36613780
- Schiavoni, V.; Campagna, R.; Pozzi, V.; Cecati, M.; Milanese, G.; Sartini, D.; Salvolini, E.; Galosi, A.B.; Emanuelli, M. Recent advances in the management of clear cell renal cell carcinoma: novel biomarkers and targeted therapies. Cancers, 2023, 15(12), 3207. doi: 10.3390/cancers15123207 PMID: 37370817
- Bray, F.; Laversanne, M.; Sung, H.; Ferlay, J.; Siegel, R.L.; Soerjomataram, I.; Jemal, A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2024, 74(3), 229-263. doi: 10.3322/caac.21834 PMID: 38572751
- Altobelli, E.; Latella, G.; Morroni, M.; Licini, C.; Tossetta, G.; Mazzucchelli, R.; Profeta, V.F.; Coletti, G.; Leocata, P.; Castellucci, M.; Guerrieri, M.; Petrocelli, R.; De Berardis, B.; De Padova, M.; Di Leonardo, G.; Paladini, A.; Mignosi, F.; Quaglione, G.; Fagnano, R.; Marzioni, D. Low HtrA1 expression in patients with long-standing ulcerative colitis and colorectal cancer. Oncol. Rep., 2017, 38(1), 418-426. doi: 10.3892/or.2017.5700 PMID: 28586045
- Antoszczak, M.; Mielczarek-Puta, M.; Struga, M.; Huczyński, A. Urea and thiourea derivatives of salinomycin as agents targeting malignant colon cancer cells. Anticancer. Agents Med. Chem., 2024, 25, 330-338. doi: 10.2174/0118715206322603241002064435 PMID: 39390831
- Fantone, S.; Marzioni, D.; Tossetta, G. NRF2/KEAP1 signaling inhibitors in gynecologic cancers. Expert Rev. Anticancer Ther., 2024, 1-4. doi: 10.1080/14737140.2024.2438951 PMID: 39636348
- Tossetta, G.; Fantone, S.; Togni, L.; Santarelli, A.; Olivieri, F.; Marzioni, D.; Rippo, M.R. Modulation of NRF2/KEAP1 signaling by phytotherapeutics in periodontitis. Antioxidants, 2024, 13(10), 1270. doi: 10.3390/antiox13101270 PMID: 39456522
- Tossetta, G.; Fantone, S.; Marzioni, D.; Mazzucchelli, R. Role of natural and synthetic compounds in modulating NRF2/KEAP1 signaling pathway in prostate cancer. Cancers, 2023, 15(11), 3037. doi: 10.3390/cancers15113037 PMID: 37296999
- Bacchetti, T.; Campagna, R.; Sartini, D.; Cecati, M.; Morresi, C.; Bellachioma, L.; Martinelli, E.; Rocchetti, G.; Lucini, L.; Ferretti, G.; Emanuelli, M. C. spinosa L. subsp. rupestris phytochemical profile and effect on oxidative stress in normal and cancer cells. Molecules, 2022, 27(19), 6488. doi: 10.3390/molecules27196488 PMID: 36235028
- Batool, S.; Asim, L.; Raffaq Qureshi, F.; Masood, A.; Mushtaq, M.; Saleem, R.S.Z. Molecular targets of plant-based alkaloids and polyphenolics in liver and breast cancer- an insight into anticancer drug development. Anticancer. Agents Med. Chem., 2024, 24. doi: 10.2174/0118715206302216240628072554 PMID: 38963106
- Imbesi Bellantoni, M.; Picciolo, G.; Pirrotta, I.; Irrera, N.; Vaccaro, M.; Vaccaro, F.; Squadrito, F.; Pallio, G. Oral cavity squamous cell carcinoma: An update of the pharmacological treatment. Biomedicines, 2023, 11(4), 1112. doi: 10.3390/biomedicines11041112 PMID: 37189730
- Schiavoni, V.; Emanuelli, M.; Sartini, D.; Salvolini, E.; Pozzi, V.; Campagna, R. Curcumin and its analogues in oral squamous cell carcinoma: State-of-the-art and therapeutic potential. Anticancer. Agents Med. Chem., 2024, 24. doi: 10.2174/0118715206297840240510063330 PMID: 38757321
Қосымша файлдар
